- It is a genuine pharmaceutical, not a supplement — synthesised in 1876 and FDA-approved as the treatment for methaemoglobinaemia.
- It can act as an alternative electron carrier, accepting and donating electrons in the mitochondrial chain and bypassing a blocked step.
- The dose response is hormetic and it reverses. Low doses support mitochondrial function; higher doses do the opposite. More is emphatically not better.
- Two screens are non-negotiable. G6PD deficiency, and any serotonergic medication — methylene blue is a monoamine oxidase inhibitor.
- Purity matters enormously. Industrial and aquarium-grade methylene blue contains heavy metal contaminants and is not the same product.
What methylene blue actually is
Patients are often surprised to learn this is not a wellness compound that drifted into medicine. It went the other way.
Methylene blue was synthesised in 1876 as a textile dye. Paul Ehrlich, who essentially founded modern chemotherapy, noticed it stained certain tissues selectively and used it to treat malaria — making it, by most accounts, the first fully synthetic drug ever used in humans.
It remains an FDA-approved medication today, used intravenously as the standard treatment for methaemoglobinaemia, a condition where haemoglobin cannot release oxygen properly. It is on the World Health Organization's list of essential medicines.
What has brought it back into interest is a separate property entirely: what it does inside the mitochondria.
The electron bypass, and why it is unusual
This is the mechanism that makes methylene blue genuinely different from every other mitochondrial support we use.
Your mitochondria produce ATP by passing electrons down a chain of protein complexes. If one of those complexes is damaged or inhibited — by toxins, by ageing, by a viral illness, by inherited variation — the chain backs up. Energy production falls and, because the electrons have nowhere to go, oxidative stress rises.
Methylene blue can accept electrons at one point in the chain and donate them further along, bypassing the blocked complex entirely. It is described in the literature as an alternative electron carrier, and it is one of very few compounds that can do this.
The consequence is worth stating clearly. In most situations, improving energy production means increasing oxidative stress as a by-product. Here the opposite happens: because the electrons stop backing up, ATP rises and oxidative stress falls at the same time. That combination is rare, and it is the reason this compound has held interest for nearly 150 years.
Why dose decides everything
This is the part that matters most, and the part most commonly got wrong by people buying it online.
Methylene blue has a hormetic dose response that actually reverses direction. At low doses it acts as the electron carrier described above and behaves as an antioxidant. At higher doses it becomes a pro-oxidant and starts doing the opposite — interfering with the same chain it was supporting.
Clinically we work in the region of 0.5 to 2 mg per kilogram, and often start considerably lower. That is a small amount, and it is deliberately small. The people who take large doses because they felt something at a small one are moving themselves onto the wrong side of the curve.
The other thing worth knowing is purity. Methylene blue is sold industrially as a dye and in aquarium shops as a fish treatment, and those products can contain heavy metal contaminants. Pharmaceutical-grade, USP-verified material from a licensed pharmacy is the only version that belongs in a person. It costs more. It is not optional.
The two things we screen for, without exception
Both of these are genuinely serious, and both are simple to check before anyone takes a first dose.
G6PD deficiency. Glucose-6-phosphate dehydrogenase protects red blood cells from oxidative stress, and it is essentially their only defence. In someone deficient, methylene blue can cause red cells to break down — which is a genuine medical emergency. Roughly one in twenty people carries some degree of deficiency and almost none of them know. One inexpensive test, done once in a lifetime, settles it.
Serotonergic medication. Methylene blue is a potent monoamine oxidase inhibitor. Combined with an SSRI, SNRI, tricyclic, MAOI, triptan or several other serotonergic drugs, it can precipitate serotonin syndrome, which is dangerous. This is not a theoretical interaction — the FDA has issued specific warnings about it.
Also worth knowing before your first dose: it will turn your urine blue-green, and sometimes your tongue. That is expected and harmless, and patients who have not been told find it alarming.
It is not appropriate in pregnancy, in significant kidney impairment, or alongside the medications above.
The ten reasons people come to us for methylene blue
Ranked by how directly the mechanism applies and how strong the supporting evidence is.
Mitochondrial Dysfunction and Fatigue
The core use and the clearest mechanism. Where the electron transport chain is impaired — after a viral illness, from toxic exposure, or with age — an alternative electron carrier addresses the problem directly rather than working around it.
What the evidence showsMethylene blue accepts electrons from NADH and donates them to cytochrome c, bypassing complexes I through III. Tucker and colleagues reviewed this alternative electron carrier mechanism in Molecular Neurobiology.Cognitive Support and Brain Energy
Your brain is the most metabolically demanding tissue you have and methylene blue crosses into it readily. Low-dose work has shown effects on memory-related brain activity, and this is among the more active research areas.
What the evidence showsRodriguez and colleagues used functional MRI to demonstrate that low-dose methylene blue increased functional MR activity in brain regions supporting short-term memory and attention, published in Radiology.Long COVID and Post-Viral Illness
Where the timeline begins with an infection and energy never returned, mitochondrial dysfunction is often central. This is one of the groups where we see the clearest response, and it pairs particularly well with hyperbaric oxygen.
What the evidence showsPost-viral fatigue involves documented electron transport chain impairment. An alternative electron carrier addresses that specific defect rather than supplying substrate to a blocked pathway.Neuroprotection and Healthy Brain Aging
Preclinical work on tau protein, amyloid and mitochondrial function in neurodegeneration has been genuinely interesting. Human trials have been mixed, and I would rather patients hear that from me than discover it later.
What the evidence showsPreclinical work has examined methylene blue effects on tau aggregation, amyloid processing and mitochondrial function in neurodegeneration models. Human trial results have been mixed and the derivative compounds remain under study.Mood Support
Methylene blue has monoamine oxidase inhibiting activity, which is the same mechanism as an older class of antidepressant. That is also precisely why it cannot be combined with modern antidepressants, and why this use requires careful medication review.
What the evidence showsMethylene blue is a potent monoamine oxidase inhibitor, which underlies both its mood effects and its serious interaction with serotonergic medication. The FDA issued a specific safety communication on this interaction in 2011.Antimicrobial and Antiviral Activity
Its original medical use was as an antimalarial, and it retains activity against a range of organisms. In chronic infection protocols it is sometimes used as an adjunct rather than a primary agent.
What the evidence showsMethylene blue was first used medically by Paul Ehrlich as an antimalarial, making it among the earliest synthetic drugs used in humans. It retains documented antimicrobial and antiviral activity.Oxygen Utilisation
The approved indication — methaemoglobinaemia — is fundamentally about restoring haemoglobin's ability to release oxygen. That same property is of interest wherever oxygen delivery is part of the picture.
What the evidence showsMethylene blue is the FDA-approved treatment for methaemoglobinaemia, reducing ferric haemoglobin back to the ferrous state so it can bind and release oxygen normally. It appears on the WHO essential medicines list.Metabolic and Insulin Signalling
Mitochondrial function and insulin sensitivity are closely linked, and preclinical work suggests effects on glucose handling. Early, mechanistically reasonable, and not a reason to use it on its own.
What the evidence showsMitochondrial function and insulin signalling are closely linked, and preclinical work suggests methylene blue influences glucose handling through improved electron transport efficiency.Alongside Photobiomodulation
There is genuine interest in combining methylene blue with red and near-infrared light, since both act on the mitochondrial chain by different routes. We use them together in some protocols.
What the evidence showsMethylene blue and photobiomodulation both act on the mitochondrial electron transport chain by different routes, and their combination has been examined in preclinical neuroprotection models.Longevity and Cellular Aging
Mitochondrial decline is one of the recognised hallmarks of aging, and this compound acts on it directly. It is one of the more interesting things in the longevity space and one of the least proven in humans.
What the evidence showsRojas and colleagues reviewed the neurometabolic mechanisms of methylene blue in Progress in Neurobiology, describing the hormetic dose response in which low doses enhance and high doses inhibit mitochondrial function.What patients commonly experience under our care
When patients receive the proper guidance, here is what they commonly experience under our care.
- The first dose — clarity, and blue urine. Many patients notice mental clarity within a few hours, which is consistent with a compound acting directly on brain mitochondria. The urine colour is expected and harmless.
- The first week — energy that holds. Not stimulation. Patients describe capacity through a full day, which is what improved ATP production feels like rather than what a stimulant feels like.
- Weeks 2–4 — cognitive endurance. Sustained thinking rather than simply clearer thinking — getting through a demanding day without the mental exhaustion that used to arrive mid-afternoon.
- Across a course — measured alongside everything else. We track hs-CRP where inflammation was part of the picture, and we reassess the underlying driver. Methylene blue is a tool within a protocol, not a protocol on its own.
If your energy has never come back after an illness, or your thinking is not what it was, methylene blue may be part of the answer — but only once we know what is actually driving it. Schedule a consultation and let my team find the root cause, screen you properly, and tell you honestly whether this is the right tool for your case.
We screen G6PD and your full medication list first, then tell you honestly whether this is the right lever for what is actually going on.
Common questions
What does methylene blue do?
It acts as an alternative electron carrier in the mitochondrial electron transport chain, accepting electrons at one point and donating them further along. That allows energy production to continue past a damaged or inhibited step. The unusual consequence is that ATP production rises while oxidative stress falls, because electrons stop backing up in the chain.
Is methylene blue safe?
At correct low doses with proper screening, it has a long safety record — it is an FDA-approved medication on the WHO essential medicines list. Two screens are non-negotiable: G6PD deficiency, because methylene blue can cause red cell breakdown in deficiency, and any serotonergic medication, because methylene blue is a monoamine oxidase inhibitor and the combination can cause serotonin syndrome.
What is the correct methylene blue dose?
Clinically we work in the region of 0.5 to 2 mg per kilogram of body weight, often starting lower. The dose response is hormetic and it reverses — low doses support mitochondrial function while higher doses become pro-oxidant and do the opposite. This is a compound where taking more actively works against you.
Can I buy methylene blue online?
We would advise against it. Methylene blue sold as a dye or as an aquarium treatment can contain heavy metal contaminants and is not manufactured to any standard intended for human use. Pharmaceutical-grade, USP-verified material from a licensed pharmacy is the only version we will use.
Why does methylene blue turn your urine blue?
Because it is a dye, and a proportion is excreted unchanged through the kidneys. Blue-green urine is expected, harmless, and resolves within a day or two of stopping. It sometimes stains the tongue temporarily as well. Patients who have not been warned find this alarming, which is why we mention it before the first dose.
- Tucker D, Lu Y, Zhang Q. From mitochondrial function to neuroprotection — an emerging role for methylene blue. Molecular Neurobiology. 2018;55(6):5137–5153. PMC5826781
- Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology. 2012;96(1):32–45. PMC3265679
- Rodriguez P, Zhou W, Barrett DW, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516–526.
- U.S. Food and Drug Administration. Drug Safety Communication: serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. 2011.
This article is educational and reflects the published literature as of August 2026. It is not a diagnosis or a treatment recommendation for any individual, and any decision about your care belongs in a conversation with a licensed practitioner who has seen your history and your labs.